These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 3856076)

  • 41. [Diagnostic value of CA 19-9 and CEA in gastrointestinal pathology].
    Patai A; Héber S; Döbrönte Z; Kovács LG
    Orv Hetil; 1992 May; 133(21):1301-4, 1307. PubMed ID: 1603581
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [CA-19-9, CA50 and CEA in pancreatic and gastrointestinal tumors. Comparative studies].
    Dienst C; Clodius T; Oldörp T; Uhlenbruck G; Diehl V
    Med Klin (Munich); 1987 Jan; 82(2):45-50. PubMed ID: 3470595
    [No Abstract]   [Full Text] [Related]  

  • 43. CA 72-4 compared with CEA and CA 19-9 as a marker of some gastrointestinal malignancies.
    Lopez JB; Royan GP; Lakhwani MN; Mahadaven M; Timor J
    Int J Biol Markers; 1999; 14(3):172-7. PubMed ID: 10569140
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic accuracy of a new tumor serologic marker, CA 19-9: comparison with CEA.
    Civardi G; Cerri L; Cavanna L; Fornari F; Di Stasi M; Binelli F
    Tumori; 1986 Dec; 72(6):621-4. PubMed ID: 3468674
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.
    Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ
    Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Simultaneous radioimmunoassay for carcinoembryonic antigen (CEA) and alpha-fetoprotein (alphaFP) in neoplasms of the gastro-intestinal tract.
    McIntire KR; Waldmann TA; Go VL; Moertel CG; Ravry M
    Ann Clin Lab Sci; 1974; 4(2):104-8. PubMed ID: 4819750
    [No Abstract]   [Full Text] [Related]  

  • 47. [Evaluation of combined CA-19-9 and CEA assay in monitoring recurrences and metastases of colorectal cancer].
    Yu BM
    Zhonghua Wai Ke Za Zhi; 1992 Dec; 30(12):707-9, 777. PubMed ID: 1339738
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical evaluation of CA 19-9 for the detection of malignant tumors--a comparison with CEA and IAP].
    Furukawa M; Kazaka S; Kushibiki K; Ashida Y; Saito H; Yamamoto H; Furukawa T
    Gan No Rinsho; 1984 Apr; 30(4):357-62. PubMed ID: 6587133
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer.
    Ychou M; Duffour J; Kramar A; Gourgou S; Grenier J
    Dis Markers; 2000; 16(3-4):105-10. PubMed ID: 11381189
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Carcinoembryonic antigen (CEA) in diagnosis and prognosis of colorectal carcinoma.
    Arnaud JP; Koehl C; Adloff M
    Dis Colon Rectum; 1980 Apr; 23(3):141-4. PubMed ID: 7379666
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Carcinoembryonic antigen (CEA). A prospective clinical trail in patients with gastrointestinal cancer.
    Kjaer M; Fischerman K
    Scand J Gastroenterol Suppl; 1976; 37():99-106. PubMed ID: 1064149
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The tumor-associated antigen CA 19-9 in the differential diagnosis and course control of malignancies of the pancreas and the gastrointestinal tract].
    Klapdor R; Greten H
    Dtsch Med Wochenschr; 1984 Dec; 109(50):1935-9. PubMed ID: 6210188
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparison of tumor M2-pyruvate kinase (tumor M2-PK), carcinoembryonic antigen (CEA), carbohydrate antigens CA 19-9 and CA 72-4 in the diagnosis of gastrointestinal cancer.
    Schneider J; Schulze G
    Anticancer Res; 2003; 23(6D):5089-93. PubMed ID: 14981971
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of monoclonal antibody-defined tumor markers in four carcinomas.
    Wu JT
    Ann Clin Lab Sci; 1989; 19(1):17-26. PubMed ID: 2916833
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumour markers in colorectal cancer.
    Roberts PJ
    Scand J Gastroenterol Suppl; 1988; 149():50-8. PubMed ID: 3201159
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical evaluation of M43: a novel cancer-associated mucin epitope.
    Goodgame R; Kiefe C; Rose E; Sutton F; Brown J; Alpert E
    Cancer Res; 1993 Jun; 53(12):2803-9. PubMed ID: 7684947
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The value of tumor markers in colorectal cancer].
    Peters KM; Grundmann R
    Leber Magen Darm; 1989 Jan; 19(1):18-25. PubMed ID: 2927234
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumour markers in pancreatic cancer.
    Haglund C; Roberts PJ; Kuusela P; Jalanko H
    Scand J Gastroenterol Suppl; 1986; 126():75-8. PubMed ID: 3470921
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Antigens (CEA and CA 19-9) in diagnosis and prognosis colorectal cancer].
    Grotowski M
    Pol Merkur Lekarski; 2002 Jan; 12(67):77-80. PubMed ID: 11957811
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Carcinoembryonic antigen (CEA) in gastric juice or feces as an aid in the diagnosis of gastrointestinal cancer.
    Fujimoto S; Kitsukawa U; Itoh K
    Ann Surg; 1979 Jan; 189(1):34-8. PubMed ID: 758861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.